Johnson & Johnson has asked hospitals to stop using one of their products in hysterectomy procedures over concern that the device may spread cancer to other parts of the body.
According to USA Today, “In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them. Surgeons use the devices to perform hysterectomies and treat painful fibroids, either by removing the growths themselves or the entire uterus. J&J said Wednesday it is conducting a worldwide withdrawal of all its morcellators still on the market.” The Wall St. Journal quoted on J&J’s paid consultants concerning the severity of the issue. “The bottom line is that it looks like the sarcoma risk is much higher than we originally thought,” said Steven McCarus, a paid Ethicon consultant and the chief of gynecological surgery at Florida Hospital Celebration Health, which was one of the chief J&J training sites for the morcellator device. The J&J surgical device is known as the laparoscopic power morcellator.
- Epidurals and Autism - October 30, 2020
- 1 in 20 Patients Harmed by Medical Errors, New Report Finds - August 1, 2019
- Errors in Electronic Health Records: A Growing Source forMedical Malpractice Claims - May 23, 2018